Partners in crime: Genes within an amplicon collude to globally deregulate chromatin in lymphoma
- PMID: 21156276
- PMCID: PMC3032418
- DOI: 10.1016/j.ccr.2010.11.032
Partners in crime: Genes within an amplicon collude to globally deregulate chromatin in lymphoma
Abstract
In this issue of Cancer Cell, Rui et al. identify JAK2 and JMJDC2 as two contiguous, coamplified oncogenes in primary mediastinal B cell and Hodgkin lymphoma. Together, JAK2 and JMJD2C induce major changes in chromatin structure and gene expression. Targeting these proteins with small molecules represents a new avenue for therapy.
Copyright © 2010 Elsevier Inc. All rights reserved.
Comment on
- 
  
  Cooperative epigenetic modulation by cancer amplicon genes.Cancer Cell. 2010 Dec 14;18(6):590-605. doi: 10.1016/j.ccr.2010.11.013. Cancer Cell. 2010. PMID: 21156283 Free PMC article.
References
- 
    - Chahine MN, Pierce GN. Therapeutic targeting of nuclear protein import in pathological cell conditions. Pharmacol Rev. 2009;61:358–372. - PubMed
 
- 
    - Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, Antal T, Hansen KH, Helin K. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature. 2006;442:307–311. - PubMed
 
- 
    - Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, et al. Molecular diagnosis of Burkitt's lymphoma. New Engl J Med. 2006;354:2431–2442. - PubMed
 
- 
    - Hamada S, Suzuki T, Mino K, Koseki K, Oehme F, Flamme I, Ozasa H, Itoh Y, Ogasawara D, Komaarashi H, et al. Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors. J Med Chem. 2010;53:5629–5638. - PubMed
 
Publication types
Grants and funding
LinkOut - more resources
- Full Text Sources
- Miscellaneous
 
        